Medtronic receives Health Canada licence for GI Genius intelligent endoscopy module with artificial intelligence system for colonoscopy Medical Device Investing
Merck's KEYTRUDA® Approved in Japan in Combination With Chemotherapy for First-Line Treatment of Patients Withd-in-japan-in-combination-with-chemotherapy-for-first-line-treatment-of-patients-with-radically-unresectab Radically Unresectable, Advanced or Recurrent Esophageal Carcinoma Pharmaceutical Investing
FDA Accepts Regulatory Submission of Supplemental New Drug Application for LYNPARZA® as Adjuvant Treatment in BRCA-Mutated, HER2-Negative High-Risk Early Breast Cancer and Grants Priority Review Pharmaceutical Investing
SHAREHOLDER ALERT: CLAIMSFILER REMINDS BMY, OWLT, PTON, ZG INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits Pharmaceutical Investing
Hollister Biosciences Announces Third Quarter Fiscal 2021 Financial Results Including Revenue of USD $14.5M and Adjusted Ebitda of USD $1.2M Psychedelics Investing
Beyond Medical Technologies Ramps Up COVID Mask Manufacturing in Response to New South Africa COVID Variant Medical Device Investing
iX Biopharma Signs Exclusive License Agreement For Wafermine And Other Sublingual Ketamine Wafer Products Psychedelics Investing
Gilead's Bold Ambition of Transforming Triple-Negative Breast Cancer Treatment to Be Highlighted With New Data at SABCS Pharmaceutical Investing
Marvel Biosciences Reports MB-204 as Highly Effective at Treating Autism Behaviours in Shank3 Mouse Model
